Gene · 710
NIH grants1,786
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 1,786
Download this page as JSON| Grant | Title | SERPING1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI116525 | MmpL3 as a target for novel anti-TB agents | 1 | 2024 |
| R01AI147778 | Natural killer cell regulation of the germinal center HIV neutralizing antibody response | 1 | 2024 |
| R01AI148543 | Antibody therapy of MRSA colonization and infection | 1 | 2024 |
| R01AI149431 | Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease | 1 | 2024 |
| R01AI151059 | Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation | 1 | 2024 |
| R01AI155716 | Glycoengineering of antibodies to modulate immune functions | 1 | 2024 |
| R01AI157138 | ILC2 memory in asthma | 1 | 2024 |
| R01AI184203 | Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | 1 | 2024 |
| R01CA238217 | Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers | 1 | 2024 |
| R01CA249054 | Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes | 1 | 2024 |
| R01DK032493 | Natural History of Pre-Diabetic Autoimmunity (DAISY) | 1 | 2024 |
| R01ES031253 | Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | 1 | 2024 |
| R01EY031209 | Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid | 1 | 2024 |
| R01EY032458 | New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis | 1 | 2024 |
| R01GM135473 | Computational tools to aid the design of glycomimetic agents | 1 | 2024 |
| R01GM139876 | Developing new tools to probe membrane protein-lipid interactions for biomedical applications | 1 | 2024 |
| R01HD056465 | Genome Wide Association Study for Childhood Obesity | 1 | 2024 |
| R01HL104165 | Structure-function of cytoprotective coagulation proteases and their receptors | 1 | 2024 |
| R01HL149891 | Mechanical Stress-Dependent Remodeling of the Cardiac Microtubule Network | 1 | 2024 |
| R01HL153235 | Mechanisms of platelet reprogramming during influenza infection | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/grants?page=21